Author | John F. Seymour, MBBS, FRACP, PhD | OncLive

Author | John F. Seymour, MBBS, FRACP, PhD

Articles

Dr. Seymour Discusses the Results of the PRIMA Study

April 28, 2014

Video

John F. Seymour, MBBS, FRACP, PhD, from the Department of Hematology at the Peter MacCallum Cancer Centre in East Melbourne, Australia, discusses the results of the PRIMA study, which evaluated the benefit of maintenance therapy with rituximab after induction of response with chemotherapy plus rituximab in comparison with no maintenance therapy in patients with advanced follicular lymphoma.

Dr. Seymour on the Efficacy of ABT-199 in High-Risk CLL

December 08, 2013

Video

John F. Seymour, MBBS, FRACP, PhD, discusses the efficacy of single-agent ABT-199 (GDC-0199), a novel Bcl-2 inhibitor, in high-risk relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.

x